Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Mar;71(3):2303–2309. doi: 10.1128/jvi.71.3.2303-2309.1997

Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.

M Lagranderie 1, A M Balazuc 1, B Gicquel 1, M Gheorghiu 1
PMCID: PMC191339  PMID: 9032366

Abstract

Recombinant live Mycobacterium bovis BCG vectors (rBCG) induce strong cellular and humoral immune responses against various antigens after either systemic or oral immunization of mice. Cytotoxic T-lymphocyte (CTL) responses may contribute to the control of human immunodeficiency virus (HIV) or simian immunodeficiency virus (SIV) infections whose portal of entry is the gastrointestinal or genital mucosa. In this study, we immunized BALB/c mice with a recombinant BCG SIV nef and observed its behavior in oropharyngeal and target organ lymphoid tissues. The cellular immune responses, particularly the intestinal intraepithelial and systemic CTL responses, were investigated. The results showed that rBCG SIV nef translocated the oropharyngeal mucosa and intestinal epithelium. It diffused to and persisted in target lymphoid organs. Specific SIV Nef peptide proliferative responses and cytokine production were observed. Strong systemic and mucosal CTL responses were induced. In particular, we demonstrated direct specific anti-Nef CTL in intestinal intraepithelial CD8beta+ T cells. These findings provide evidence that orally administered rBCG SIV nef may contribute to local defenses against viral invasion. Therefore, rBCG SIV nef could be a candidate vaccine to protect against SIV infection and may be used to develop an oral rBCG HIV nef vaccine.

Full Text

The Full Text of this article is available as a PDF (174.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldovini A., Young R. A. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature. 1991 Jun 6;351(6326):479–482. doi: 10.1038/351479a0. [DOI] [PubMed] [Google Scholar]
  2. Amerongen H. M., Weltzin R., Farnet C. M., Michetti P., Haseltine W. A., Neutra M. R. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr. 1991;4(8):760–765. [PubMed] [Google Scholar]
  3. Battegay M., Kyburz D., Hengartner H., Zinkernagel R. M. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur J Immunol. 1993 Dec;23(12):3236–3241. doi: 10.1002/eji.1830231229. [DOI] [PubMed] [Google Scholar]
  4. Benveniste O., Vaslin B., Le Grand R., Fouchet P., Omessa V., Theodoro F., Fretier P., Clayette P., Boussin F., Dormont D. Interleukin 1 beta, interleukin 6, tumor necrosis factor alpha, and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251. AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):241–250. doi: 10.1089/aid.1996.12.241. [DOI] [PubMed] [Google Scholar]
  5. Chardès T., Buzoni-Gatel D., Lepage A., Bernard F., Bout D. Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J Immunol. 1994 Nov 15;153(10):4596–4603. [PubMed] [Google Scholar]
  6. Czerkinsky C. C., Nilsson L. A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983 Dec 16;65(1-2):109–121. doi: 10.1016/0022-1759(83)90308-3. [DOI] [PubMed] [Google Scholar]
  7. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 1992 Dec 18;258(5090):1938–1941. doi: 10.1126/science.1470917. [DOI] [PubMed] [Google Scholar]
  8. Dialynas D. P., Quan Z. S., Wall K. A., Pierres A., Quintáns J., Loken M. R., Pierres M., Fitch F. W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 1983 Nov;131(5):2445–2451. [PubMed] [Google Scholar]
  9. Dittmer U., Nisslein T., Bodemer W., Petry H., Sauermann U., Stahl-Hennig C., Hunsmann G. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology. 1995 Oct 1;212(2):392–397. doi: 10.1006/viro.1995.1496. [DOI] [PubMed] [Google Scholar]
  10. Fantini J., Yahi N., Chermann J. C. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9297–9301. doi: 10.1073/pnas.88.20.9297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Flores-Romo L., Bacon K. B., Estrada-Garcia T., Life P. F., Aubry J. P., Bonnefoy J. Y., Escobar-Gutiérrez A. HIV and the colonic route of entry: effect of inflammatory cytokines on the binding of HIV-gp120 and T cells to human enterocytes. Immunol Lett. 1995 Jul-Aug;47(1-2):139–140. doi: 10.1016/0165-2478(95)00064-c. [DOI] [PubMed] [Google Scholar]
  12. Füst G., Tóth F. D., Kiss J., Ujhelyi E., Nagy I., Bánhegyi D. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease. AIDS. 1994 May;8(5):603–609. doi: 10.1097/00002030-199405000-00005. [DOI] [PubMed] [Google Scholar]
  13. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med. 1995 Nov;1(11):1167–1173. doi: 10.1038/nm1195-1167. [DOI] [PubMed] [Google Scholar]
  14. Gheorghiu M. BCG-induced mucosal immune responses. Int J Immunopharmacol. 1994 May-Jun;16(5-6):435–444. doi: 10.1016/0192-0561(94)90033-7. [DOI] [PubMed] [Google Scholar]
  15. Gheorghiu M., Lagranderie M. R., Gicquel B. M., Leclerc C. D. Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen. Infect Immun. 1994 Oct;62(10):4287–4295. doi: 10.1128/iai.62.10.4287-4295.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gheorghiu M., Lagrange P. H., Fillastre C. The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine. J Biol Stand. 1988 Jan;16(1):15–26. doi: 10.1016/0092-1157(88)90025-x. [DOI] [PubMed] [Google Scholar]
  17. Goodman T., Lefrancois L. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J Exp Med. 1989 Nov 1;170(5):1569–1581. doi: 10.1084/jem.170.5.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Guy-Grand D., Griscelli C., Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med. 1978 Dec 1;148(6):1661–1677. doi: 10.1084/jem.148.6.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guy-Grand D., Malassis-Seris M., Briottet C., Vassalli P. Cytotoxic differentiation of mouse gut thymodependent and independent intraepithelial T lymphocytes is induced locally. Correlation between functional assays, presence of perforin and granzyme transcripts, and cytoplasmic granules. J Exp Med. 1991 Jun 1;173(6):1549–1552. doi: 10.1084/jem.173.6.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guy-Grand D., Vassalli P. Gut intraepithelial T lymphocytes. Curr Opin Immunol. 1993 Apr;5(2):247–252. doi: 10.1016/0952-7915(93)90012-h. [DOI] [PubMed] [Google Scholar]
  21. Honda M., Matsuo K., Nakasone T., Okamoto Y., Yoshizaki H., Kitamura K., Sugiura W., Watanabe K., Fukushima Y., Haga S. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10693–10697. doi: 10.1073/pnas.92.23.10693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hussain L. A., Kelly C. G., Rodin A., Jourdan M., Lehner T. Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium. Clin Exp Immunol. 1995 Nov;102(2):384–388. doi: 10.1111/j.1365-2249.1995.tb03794.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kalyanaraman V. S., Cabradilla C. D., Getchell J. P., Narayanan R., Braff E. H., Chermann J. C., Barré-Sinoussi F., Montagnier L., Spira T. J., Kaplan J. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science. 1984 Jul 20;225(4659):321–323. doi: 10.1126/science.6330889. [DOI] [PubMed] [Google Scholar]
  24. Kameoka M., Nishino Y., Matsuo K., Ohara N., Kimura T., Yamazaki A., Yamada T., Ikuta K. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine. 1994 Feb;12(2):153–158. doi: 10.1016/0264-410x(94)90054-x. [DOI] [PubMed] [Google Scholar]
  25. Klavinskis L. S., Bergmeier L. A., Gao L., Mitchell E., Ward R. G., Layton G., Brookes R., Meyers N. J., Lehner T. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol. 1996 Sep 15;157(6):2521–2527. [PubMed] [Google Scholar]
  26. Lagranderie M. R., Balazuc A. M., Deriaud E., Leclerc C. D., Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun. 1996 Jan;64(1):1–9. doi: 10.1128/iai.64.1.1-9.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lagranderie M., Murray A., Gicquel B., Leclerc C., Gheorghiu M. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine. 1993 Oct;11(13):1283–1290. doi: 10.1016/0264-410x(93)90096-g. [DOI] [PubMed] [Google Scholar]
  28. Lehner T., Brookes R., Panagiotidi C., Tao L., Klavinskis L. S., Walker J., Walker P., Ward R., Hussain L., Gearing J. H. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8638–8642. doi: 10.1073/pnas.90.18.8638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Letvin N. L., Daniel M. D., Sehgal P. K., Desrosiers R. C., Hunt R. D., Waldron L. M., MacKey J. J., Schmidt D. K., Chalifoux L. V., King N. W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science. 1985 Oct 4;230(4721):71–73. doi: 10.1126/science.2412295. [DOI] [PubMed] [Google Scholar]
  30. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993 Mar;57(1):183–289. doi: 10.1128/mr.57.1.183-289.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. London S. D., Rubin D. H., Cebra J. J. Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches. J Exp Med. 1987 Mar 1;165(3):830–847. doi: 10.1084/jem.165.3.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  33. Mega J., McGhee J. R., Kiyono H. Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. J Immunol. 1992 Apr 1;148(7):2030–2039. [PubMed] [Google Scholar]
  34. Offit P. A., Cunningham S. L., Dudzik K. I. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol. 1991 Mar;65(3):1318–1324. doi: 10.1128/jvi.65.3.1318-1324.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pierres M., Goridis C., Golstein P. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol. 1982 Jan;12(1):60–69. doi: 10.1002/eji.1830120112. [DOI] [PubMed] [Google Scholar]
  36. Sabin A. B. Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8852–8855. doi: 10.1073/pnas.89.18.8852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  38. Taguchi T., McGhee J. R., Coffman R. L., Beagley K. W., Eldridge J. H., Takatsu K., Kiyono H. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods. 1990 Mar 27;128(1):65–73. doi: 10.1016/0022-1759(90)90464-7. [DOI] [PubMed] [Google Scholar]
  39. Tsubota H., Lord C. I., Watkins D. I., Morimoto C., Letvin N. L. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med. 1989 Apr 1;169(4):1421–1434. doi: 10.1084/jem.169.4.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Walker C. M., Moody D. J., Stites D. P., Levy J. A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986 Dec 19;234(4783):1563–1566. doi: 10.1126/science.2431484. [DOI] [PubMed] [Google Scholar]
  41. Winter N., Lagranderie M., Gangloff S., Leclerc C., Gheorghiu M., Gicquel B. Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine. 1995 Apr;13(5):471–478. doi: 10.1016/0264-410x(94)00001-4. [DOI] [PubMed] [Google Scholar]
  42. Winter N., Lagranderie M., Rauzier J., Timm J., Leclerc C., Guy B., Kieny M. P., Gheorghiu M., Gicquel B. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene. 1991 Dec 20;109(1):47–54. doi: 10.1016/0378-1119(91)90587-2. [DOI] [PubMed] [Google Scholar]
  43. Yasutomi Y., Koenig S., Woods R. M., Madsen J., Wassef N. M., Alving C. R., Klein H. J., Nolan T. E., Boots L. J., Kessler J. A. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J Virol. 1995 Apr;69(4):2279–2284. doi: 10.1128/jvi.69.4.2279-2284.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES